Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pharmacy staff profile

Associate Professor Rhiannon Braund

PositionAssociate Professor
QualificationsBSc BPharm PhD(Otago) MPS FNZCP RegPharmNZ
Research summaryClinical and social pharmacy; effective use of medicines
Teaching
  • QUM module coordinator
  • Clinical Pharmacy Practice

Research

  • Quality use of medicines: From prescription to disposal and beyond
  • Consequences of unused medications: Patients, financial and environmental

My research focus is the use of prescription medications and investigating the wastage as a result of non-compliance, over-supply and other factors. As this is such a multi-faceted area I have several themes including primary and secondary adherence, prescribing practices and policies, patient outcomes, storage and disposal, and the environmental impact of pharmaceuticals.

Associate Professor Braund on PubMed

Publications

Napier, P., Norris, P., & Braund, R. (2017). Introducing a checking technician allows pharmacists to spend more time on patient focused activities. Research in Social & Administrative Pharmacy. Advance online publication. doi: 10.1016/j.sapharm.2017.05.002

Campbell, C., Braund, R., & Morris, C. (2017). Beyond the four walls: An exploratory survey of location, employment and roles of pharmacists in primary health care. Journal of Primary Health Care, 9(4), 297-310. doi: 10.1071/HC17022

Peake, B. M., Braund, R., Tong, A. Y. C., & Tremblay, L. A. (2016). The life-cycle of pharmaceuticals in the environment. Cambridge, UK: Woodhead Publishing, 261p.

Braund, R., Henderson, E., McNab, E., Sarten, R., Wallace, E., & Gauld, N. (2016). Pharmacist-only trimethoprim: Pharmacist satisfaction on their training and the impact on their practice. International Journal of Clinical Pharmacy, 38(6), 1357-1361. doi: 10.1007/s11096-016-0388-0

Assawasuwannakit, P., Braund, R., & Duffull, S. B. (2016). A framework for quantifying the influence of adherence and dose individualization. Clinical Pharmacology & Therapeutics, 99(4), 452-459. doi: 10.1002/cpt.268